Middle Meningeal Artery Embolization Minimizes Burdensome Recurrence Rates After Newly Diagnosed Chronic Subdural Hematoma Evacuation (MEMBRANE): study protocol for a randomized controlled trial

Alexander Hoenning,Johannes Lemcke,Sergej Rot,Dirk Stengel,Berthold Hoppe,Kristina Zappel,Patrick Schuss,Sven Mutze,Leonie Goelz
DOI: https://doi.org/10.1186/s13063-022-06506-3
IF: 2.728
2022-08-23
Trials
Abstract:Chronic subdural hematoma (cSDH) is the most common complication of mild traumatic brain injury demanding neurosurgery in high-income countries. If undetected and untreated, cSDH may increase intracranial pressure and cause neurological deficiencies. The first-line intervention of choice is burr hole trepanation and hematoma evacuation. However, any third patient may experience rebleeding, demanding craniotomy with excess morbidity. Adjunct endovascular embolization of the frontal and parietal branches of the middle meningeal artery (MMA) is a promising approach to avoid relapse and revision but was hitherto not studied in a randomized trial.
medicine, research & experimental
What problem does this paper attempt to address?